RL
Rupa Latha Guruvindapalli
About Rupa Latha Guruvindapalli
Data last updated:
Rupa Latha Guruvindapalli is a Director at Desbro Biosciences Private Limited (since 2025) and Director at Olea Ventures Private Limited (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is Desbro Biosciences Private Limited at ₹39.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Desbro Biosciences Private Limited U33100TG2022PTC167968 | Director | 01 Feb 2025 | 2022 | ₹39.3 Lakh (FY 2025) | Active |
| Olea Ventures Private Limited U42101AP2024PTC115532 | Director | 30 Jul 2024 | 2024 | Active |
Board colleagues of Rupa Latha Guruvindapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kummathi Sreenivasareddy | 09780811 | Desbro Biosciences Private Limited | Director |
| Mridula Guruvindapalli | 10427741 | Desbro Biosciences Private Limited , Olea Ventures Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupa Latha Guruvindapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupa Latha Guruvindapalli
Rupa Latha Guruvindapalli currently holds 2 directorships: Desbro Biosciences Private Limited (Director, since 01 Feb 2025, revenue ₹39.3 Lakh (FY 2025)); Olea Ventures Private Limited (Director, since 30 Jul 2024).
Rupa Latha Guruvindapalli was first appointed on 30 Jul 2024 as Director at Olea Ventures Private Limited. The most recent appointment on record is 01 Feb 2025 at Desbro Biosciences Private Limited.
The current boards of Rupa Latha Guruvindapalli's companies include Kummathi Sreenivasareddy (Desbro Biosciences Private Limited), Mridula Guruvindapalli (Desbro Biosciences Private Limited).